European Archives - Page 1112 of 1261 - European Medical Journal

Avanafil: The Second-Generation Treatment of Erectile Dysfunction

The main objectives of erectile dysfunction (ED) management are to control and reduce associated organic cardiovascular risk factors and to restore the…

New Evidence for Exogenous Glycosaminoglycans Treatment of ‘Cystitis': Is the Future Now?

Chronic cystitis may be due to different known causes. Current basic science research has revealed a wide consensus that chronic cystitis may arise from…

The Evolving Biosimilar Landscape: Approval of the First Etanercept Biosimilar in Europe, An Interview With Emilio Martín-Mola

On January 14th 2016, SB4 (Benepali®) received marketing authorisation application approval from the European Commission (EC). It is the first biosimilar…

Late and Very Late Stent Thrombosis in the Era of Second-Generation Drug-Eluding Stents

Stent thrombosis is a life-threatening complication of percutaneous coronary intervention that often results in ST-segment myocardial infarction or …

Spondyloarthritis: Pathogenesis, Clinical Manifestations, Diagnosis and Management

The term spondyloarthritis (SpA) is used to describe a heterogeneous group of diseases sharing certain characteristics.

Evaluation of Stress Urinary Incontinence: State-of-the-Art Review

Stress urinary incontinence (SUI) in women is an endemic and costly problem. It is associated with a significant burden on both a personal and community…

Cirrhosis: Reviewing the Literature and Future Perspectives

Cirrhosis is the final stage of chronic liver disease and has many causes, including viral hepatitis, excessive alcohol intake, and non-alcoholic…

In-Stent Restenosis After Carotid Artery Stenting: From Diagnosis to Treatment

Although carotid artery stenting is a safe and effective treatment for preventing ischaemic stroke in significant carotid atherosclerotic disease, it can…

Hepatitis C: Is Regression of Advanced Fibrosis Possible After Treatment?

Liver cirrhosis represents a severe complication for hepatitis C patients. Patients with cirrhosis require immediate treatment; a sustained virological…

Chronic Total Occlusion in Patients After Coronary Artery Bypass Grafting: A Review of Possible Interventions and Results With a Case Study

Within 10 years following a coronary artery bypass graft (CABG), only 60% of vein grafts and 90% of internal mammary artery (IMA) grafts remain patent.